Tejnaksh Health.

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE030T01027
  • NSEID:
  • BSEID: 539428
INR
15.66
-0.07 (-0.45%)
BSENSE

Dec 05

BSE+NSE Vol: 1

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Tejnaksh Healthcare Ltd stock-summary
stock-summary
Tejnaksh Healthcare Ltd
Micro Cap
Healthcare Services
Tejnaksh Healthcare Limited was incorporated in Mumbai on 18 February, 2008 as a Private Limited Company and converted into Public Limited Company with effect from 10 March, 2015 issued by the Registrar of Companies, Mumbai, Maharashtra. Tejnaksh runs an Institute of Urology, an ISO certified the international level Urology hospital, located in Dhule, Maharashtra. It provides a complete range of services from consultations and investigations to treatment for Urology.
Company Coordinates stock-summary
Company Details
A 601 Floor No 6 Kailash, Business Park Veer SavarkarMar Mumbai Maharashtra : 400079
stock-summary
Tel:
stock-summary
cs.tejnaksh@gmail.com
Registrar Details
Cameo Corporate Services Ltd , Subramanian Buildings No 1 , Club House Road, Chennai
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 10.16 Cr
Number of Shares
2.03 Cr
Face Value
INR 5.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
19-Jul-2023
2.03
10.16
10156800
5
Stock Split
26-Apr-2018
1.02
10.16
7948800
10
Bonus
08-Mar-2017
22.08
2.21
1104000
10
Bonus
08-Mar-2017
22.08
2.21
1104000
10
Bonus
27-Oct-2015
11.04
1.10
304000
10
Public Issues
27-Oct-2015
11.04
1.10
304000
10
Public Issues
31-Jan-2015
8
0.80
790000
10
Bonus
31-Jan-2015
8
0.80
790000
10
Bonus
20-Dec-2014
1
0.01
9000
10
Stock Split
20-Dec-2014
1
0.01
9000
10
Stock Split
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Ashish Vishwas Rawandale (38.15%)

Highest Public shareholder

Sheetal Utkarsh Rawandale (1.45%)

Individual Investors Holdings

23.73%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
Ashish Vishwas Rawandale
Chairman / Executive Director
5.0 lacs
Preeti Ashish Rawandale
Non-Exec & Non-Independent Dir
6.0 lacs
Kiran Madhavrao Pawar
Independent Non Exe. Director
0
Vikramsinh Satish Khatal Patil
Independent Non Exe. Director
0
SANJAY BHIKAJIRAO KHATAL
Non-Exec & Non-Independent Dir
0
Suhas Vasantrao Thorat
Independent Non Exe. Director
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Medical consumables and Drugs
0.5718
0%
 
100
Medical consumables and Drugs
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Operations & Surgery
4.99
57.91%
Medicines
1.38
15.97%
Pathology & Other Operating Revenue
1.14
13.25%
 
57.91
Operations & Surgery
42.09
Operations & Surgery
15.97
Medicines
84.03
Medicines
13.25
Pathology & Other Operating Revenue
86.75
Pathology & Other Operating Revenue
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
3 Cr
(Quarterly Results - Sep 2025)
Net Profit:
0 Cr
stock-summary
Industry

Healthcare Services

stock-summary
Market cap

INR 32 Cr (Micro Cap)

stock-summary
P/E

20.00

stock-summary
Industry P/E

24

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.03

stock-summary
Return on Equity

6.34%

stock-summary
Price to Book

1.20